The global pharmaceutical industry growth is staggering over the past few years and is also expected to reach more than $1.2 trillion in the near future. This growth is accompanied by development of new technologies with innovative business models. With this end in mind, Manyu & Company have planned to publish its research and analysis that would cater to the requirements of different stake holders in the pharmaceutical Industry’s value chain.
The various types of research will include strategic issues & discussions, pipeline insights, therapy area market analysis, technology insights, investment analysis and Pharma-IT.
According to Karthik Elam, Partner of Manyu & Company, “This move will allow Manyu & Company to expertise on all key segments of the Pharmaceutical Industry. It will also help to enhance the company’s research portfolio and drive its consulting service.”
Manyu & Company’s advanced research methodologies help their clients to obtain new insights.
